Few topics in men's health generate more heat and less light than the question of whether finasteride causes erectile dysfunction — and whether that ED can persist after stopping the drug. Here's an honest, evidence-based look at what we know, what we don't, and how to read the literature without falling into either camp's narrative.
What the Clinical Trial Data Shows
Finasteride 1mg (Propecia) was studied in large randomized controlled trials for hair loss. The pivotal trials reported sexual side effects at the following rates:
| Side Effect | Finasteride 1mg | Placebo |
|---|---|---|
| Decreased libido | 1.8% | 1.3% |
| Erectile dysfunction | 1.3% | 0.7% |
| Ejaculation disorder | 1.2% | 0.7% |
These numbers are important context. The difference between finasteride and placebo is real but small — roughly 0.5–0.6 percentage points above placebo for each sexual side effect. The vast majority of men in clinical trials (over 97%) did not experience sexual side effects.
Additionally, most men who reported side effects saw them resolve either during continued treatment or after stopping the medication.
The "Post-Finasteride Syndrome" Claim
"Post-finasteride syndrome" (PFS) refers to a constellation of symptoms — persistent ED, loss of libido, cognitive changes, depression — that some men report lasting months or years after stopping finasteride. It's a deeply contentious topic.
What supports the concern:
- Individual case reports and patient-reported surveys document real suffering in men who attribute lasting symptoms to finasteride
- The condition was added to the FDA label as a warning in 2012 (persistent sexual side effects after discontinuation)
- Some animal studies show prolonged neurosteroid changes after 5-alpha reductase inhibitor exposure
- A few small studies have found altered neurosteroid levels, penile tissue changes, or epigenetic modifications in men with self-reported PFS
What complicates the picture:
- No large, well-controlled prospective study has confirmed PFS as a distinct clinical entity
- The symptoms attributed to PFS (ED, low libido, depression, cognitive fog) are extremely common in the general male population and increase with age
- Selection bias in self-reported surveys is significant — men without problems don't typically seek out PFS forums
- Nocebo effect evidence is strong (see below)
- The mechanism by which a drug with a 6–8 hour half-life could cause permanent changes after discontinuation is not established
The Nocebo Effect: The Elephant in the Room
A landmark 2007 study illuminated how powerful expectation is in finasteride's side effect profile. Men who were told they might experience sexual side effects from finasteride reported them at three times the rate of men who were not given that warning — despite taking the same drug at the same dose.
This doesn't mean finasteride's sexual side effects are imaginary. PDE5 enzyme inhibition and altered neurosteroid metabolism are real pharmacological effects. But it does mean that the anxiety about side effects can itself cause or amplify sexual dysfunction, making it extremely difficult to separate drug effect from nocebo effect in any individual case.
Reading the Literature Fairly
Both extremes of this debate are wrong:
The dismissive position — "PFS doesn't exist, it's all in their heads" — ignores the FDA label update, the individual case reports, and the biological plausibility of prolonged neurosteroid effects. Dismissing patients' suffering is bad medicine.
The catastrophizing position — "finasteride permanently damages sexual function in a significant percentage of users" — isn't supported by the weight of evidence. The clinical trial data shows small effect sizes, most side effects resolve, and the persistent-syndrome claim lacks confirmation from controlled studies.
The honest middle ground: finasteride causes reversible sexual side effects in a small minority of users. A much smaller subset reports persistent symptoms after stopping, and we don't yet have enough high-quality data to know whether this represents a true drug effect, a nocebo response, the natural progression of conditions that coincide with finasteride use (aging, stress, depression), or some combination.
Practical Recommendations
- If you're considering finasteride for hair loss: The probability of sexual side effects is low (around 2–4% above placebo). Most cases resolve. Starting treatment in a state of anxiety about side effects may itself increase your risk through the nocebo effect.
- If you're on finasteride and notice changes: Talk to your prescriber. Options include dose reduction (some dermatologists use every-other-day dosing), switching to topical finasteride (lower systemic absorption), or discontinuation. Don't catastrophize — most men who experience side effects see improvement within weeks of stopping.
- If you stopped finasteride and symptoms persist: Seek evaluation from a urologist or endocrinologist — not an online forum. Get hormone levels tested (total T, free T, DHT, estradiol). Some symptoms attributed to finasteride may have other treatable causes.